Skip to main content

NeuroPace Inc

NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001528287

No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding NeuroPace Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of NPCE: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders4154+13
Shares12.7M13.4M+675.9K (+5.3%)
Value$130.8M$176.4M+$45.6M (+34.8%)

New holders (18)

Institutions that held NeuroPace Inc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to NPCE in Q1 2024
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc139,843$1.85M0.00%
Acadian Asset Management LLC47,215$621.0K0.00%
HRT Financial LP31,921$421.0K0.00%
Marathon Trading Investment Management LLC28,000$369.6K0.15%
Jump Financial, LLC25,538$337.1K0.01%
Petrus Trust Company, LTA23,904$315.5K0.03%
Options Solutions, LLC18,499$244.2K0.14%
XTX Topco Ltd15,412$203.4K0.03%
Brevan Howard Capital Management LP15,034$198.4K0.02%
Schonfeld Strategic Advisors LLC14,426$190.4K0.00%
Squarepoint Ops LLC13,316$175.8K0.00%
Hillsdale Investment Management Inc.11,750$155.1K0.01%
Jefferies Financial Group Inc.10,900$143.9K0.00%
Y-Intercept (Hong Kong) Ltd10,491$138.5K0.01%
UBS Group AG1,700$22.4K0.00%
EntryPoint Capital, LLC1,632$21.5K0.02%
CWM, LLC166$2.00K0.00%
Macquarie Group Ltd1,198$160.00%

Sold out (5)

Institutions that held NeuroPace Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of NPCE in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
683 Capital Management, LLC24,933$257.1K
TownSquare Capital, LLC15,859$163.5K
Virtu Financial LLC10,764$111.0K
Advisor Group Holdings, Inc.233$2.40K
Royal Bank of Canada118$1.00K